PARP inhibition induces BAX/BAK‐independent synthetic lethality of BRCA1‐deficient non‐small cell lung cancerIan Paul, Dean A. Fennell, Kathy Gately et al.|The Journal of Pathology|2011Cited by 35
Implications for Powering Biomarker Discovery StudiesSiân Dibben, Richard D. Kennedy, Robert J. Holt et al.|Journal of Molecular Diagnostics|2012Cited by 7